Bariatric Scalable Internet Treatments
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 70 |
Updated: | 1/17/2019 |
Start Date: | July 20, 2018 |
End Date: | July 19, 2019 |
Contact: | Valentina Ivezaj, Ph.D. |
Email: | valentina.ivezaj@yale.edu |
Phone: | 203-785-7210 |
Randomized Clinical Trial Testing Two Scalable Internet-Based Weight Loss Treatments Following Bariatric Surgery
The purpose of the study is to conduct a randomized clinical trial examining the feasibility
and effectiveness of two guided self-help behavioral weight loss (gshBWL) treatments
delivered via the internet for individuals struggling with weight loss one year following
bariatric surgery. The two treatments will consist of 1) gshBWL delivered through the
internet only (gshBWL-I) and 2) gshBWL delivered via the internet with additional
complementary phone sessions (gshBWL-IP).
and effectiveness of two guided self-help behavioral weight loss (gshBWL) treatments
delivered via the internet for individuals struggling with weight loss one year following
bariatric surgery. The two treatments will consist of 1) gshBWL delivered through the
internet only (gshBWL-I) and 2) gshBWL delivered via the internet with additional
complementary phone sessions (gshBWL-IP).
Inclusion Criteria:
- gastric bypass and sleeve surgery patients from Yale's Bariatric/Gastrointestinal
Surgery Program
- surgery 1-2 years prior
- <60% excess weight loss
- able to read English proficiently enough to read the patient self-help materials and
study assessments
- available for the duration of the treatment
- availability of internet and phone to participate in study interventions
- agree to the study procedures
Exclusion Criteria:
- medical status judged by the surgeon as contraindication (rare instances of need for
additional surgery or medical instability)
- unable to ambulate
- current medications that influence eating/weight
- current substance dependence or other severe psychiatric disturbance (e.g.,
suicidality) that requires immediate treatment.
We found this trial at
1
site
New Haven, Connecticut 06519
Principal Investigator: Valentina Ivezaj, Ph.D.
Phone: 203-785-7210
Click here to add this to my saved trials